Connect with us

Technology

Canadian-made video game designed to help maintain abilities and quality of life for children with rare, degenerative neuromuscular disease

Published

on

Free, web-based game, Cloud Bazaar, promotes physical exercise in children with spinal muscular atrophy (SMA), a rare and degenerative neuromuscular disease.Game targets need for increased therapeutic exercise adherence in pediatric SMA patients by gamifying physical activities and making them more fun.Uses motion capture technology to track players’ movements and responds with exercises that progressively challenge them according to their level of ability.

CALGARY, AB and TORONTO, Dec. 14, 2022 /CNW/ – Raft Digital Therapeutics (Raft) and Biogen Canada are excited to announce the launch of the demo version of Cloud Bazaar, an interactive therapeutic video game. Developed in Canada, Cloud Bazaar promotes physical activity in young players with Spinal Muscular Atrophy (SMA), a rare and degenerative neuromuscular disease. The game aims to help players maintain physical abilities and improve health outcomes, while promoting a higher quality of life by making at-home therapeutic exercise fun and engaging.

Equipped with motion capture technology, the game tracks and responds to movements through the built-in camera on players’ computers as they navigate increasingly difficult levels. It engages young players by placing them on a “mission” in which they fly an airship that protects the fictional city of the Cloud Bazaar. To do so, they are challenged to complete a set of guided movements that were developed in consultation with, and based on, feedback from neuromuscular disease experts and youth in the SMA community.

“The most important aspect of developing the Cloud Bazaar to us was getting active participation and feedback from young people living with SMA,” said Raft CEO and physiatrist, Dr. Geoff Frost. “Our intention is to build a gaming experience that’s not only physically beneficial and enriching for players, but that’s fun and engaging so they’re keen to keep integrating therapeutic exercise into their everyday lives. Their involvement was central to making this happen.”

“Regular therapeutic exercise is crucial for maintaining physical abilities in young SMA patients, and we are proud to introduce Cloud Bazaar as a unique online game that makes physical activity fun while also promoting social inclusivity through its diverse community of users,” said Eric Tse, General Manager of Biogen Canada. “Biogen is devoted to addressing areas of unmet patient need, and our drive to innovate led us to partner with Raft to create a made-in-Canada technology that supports this rare disease community.”

The demo version of Cloud Bazaar was also recently recognized for its interactive content and rich media in the Web-Based Digital Health category at the 2022 Digital Health Awards®. Available in English and French, Cloud Bazaar is free, web-based and doesn’t require a console, making the game highly accessible for patients and families who live with SMA and may face additional financial pressures due to the disease. It also promotes inclusivity by enabling players to invite and challenge others to play and compete, either within or outside the SMA community, regardless of their level of ability.

Raft co-developed Cloud Bazaar with founding partner, Biogen Canada.

The demo is available for download on Windows at https://cloudbazaar.io/.

About Spinal Muscular Atrophy (SMA)

SMA is a rare, debilitating neurodegenerative condition that is characterized by loss of motor neurons in the spinal cord and lower brain stem, resulting in severe and progressive muscular atrophy and weakness.  

Due to a deletion of, or mutation in, the SMN1 gene, people with SMA do not produce enough survival motor neuron (SMN) protein, which is critical for the maintenance of motor neurons. The severity of SMA correlates with the amount of SMN protein an individual has. Ultimately, individuals with SMA can become paralyzed and have difficulty performing the basic functions of life, like breathing and swallowing.

People with Type I (infantile-onset) SMA, the form that requires the most intensive and supportive care, produce very little SMN protein and do not achieve the ability to sit without support and typically do not live beyond two years without respiratory support. People with Type II and Type III SMA produce greater amounts of SMN protein and have less severe, but still life-altering forms of SMA.

About Raft Digital Therapeutics (Raft)

Raft is developing a platform designed to make at-home therapeutic exercise fun, engaging, and immersive to improve adherence and quality of life for patients. Founded by physiatrist Dr. Geoff Frost and other key members of the rare disease community, Raft is dedicated to bettering the lives of patients living with neuromuscular diseases through informed and intelligent game design, making programs that suit all users, no matter their level of motor function. For more about Raft, visit https://raftdt.com/.

About Biogen

As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and developed the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also commercializing biosimilars and focusing on advancing one of the industry’s most diversified pipelines in neuroscience that will transform the standard of care for patients in several areas of high unmet need.

Since 1998, Biogen Canada has been delivering life-changing medicines and services that support unmet treatment needs and the lives of Canadians affected by neurological conditions. As a company that founds its culture on principles of equity, diversity and inclusion, Biogen Canada is proud to have been named a Best Workplace™ for Inclusion, Giving Back and Hybrid Work. To learn more, please visit www.biogen.ca.

SOURCE Biogen Canada

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

IBSAT 2024 application deadline extended to December 23rd

Published

on

By

Step into a future of management excellence with ICFAI Business School

HYDERABAD, India, Dec. 19, 2024 /PRNewswire/ — ICFAI Business School (IBS) has extended the application deadline for IBSAT 2024 to December 23, 2024. This extension offers an opportunity for all management aspirants who couldn’t complete their applications by the previous deadline due to technical or personal reasons.

 

The IBSAT 2024 test, a gateway to IBS’s MBA/PGPM programmes at 9 campuses, is designed to assess a candidate’s verbal ability, reading comprehension, quantitative aptitude, and data interpretation skills. Key highlights include:

CAT-like Syllabus: A familiar format for aspirants already preparing for management entrance exams.Remote Proctored Test: Conducted online, allowing candidates to take the exam from the comfort of their homes.No Negative Marking: Encourages students to attempt all questions without fear of penalty.Scholarships Worth Rs 2 Lakh Each: Awarded to the top 500 rankers, recognizing academic excellence.

Additionally, IBS hosts a free mock test on ibsindia.org to help aspirants gauge their preparation levels.

IBS’s Industry-Relevant Curriculum

In today’s rapidly evolving global economy, management education must bridge the gap between theory and practice, and IBS excels in doing so. With an industry-relevant curriculum aligned to modern business demands, IBS, with its Case Based Teaching and Bloomberg/SAP Labs, provides students with the skills needed to navigate complex business scenarios. The curriculum also includes internships, industry interactions, and live projects that help students build a solid foundation for their careers.

Multiple Admission Pathways

Aspirants seeking a transformative management education with practical insights are encouraged to apply for the MBA/PGPM 2025-27 programs at IBS. In addition to IBSAT test scores, IBS also accepts CAT, NMAT, XAT, and GMAT scores, offering multiple pathways for admission. This flexibility allows candidates to choose the best route to enter IBS, making it easier for them to apply based on their strengths and available scores.

Holistic Learning Experience at IBS Campuses

IBS campuses provide a holistic learning experience, fostering personality development through vibrant club activities and practical exposure. Students engage in co-curricular and extracurricular activities ranging from domain-specific clubs focused on marketing, finance, and operations, to multidisciplinary clubs that involve live industry projects and practical learning opportunities. These activities help students develop leadership skills, team collaboration, and strategic thinking, which are critical to success in the business world.

Exceptional Placement Record

IBS has a strong commitment to career development, as evidenced by its over 95% placement rate for the class of 2024. The highest international package reached Rs 36.76 LPA, demonstrating the effectiveness of IBS’s industry connections and its ability to prepare students for lucrative global career opportunities.

Accreditations and Recognitions

IBS stands out as an AACSB-accredited institution, showcasing its academic excellence. It is ranked 39th by NIRF, holds a NAAC A++ accreditation, and is ranked 22nd by Business Today. IBS’s Case Research Center is a global leader, with award-winning case studies that are used by over 900 business schools worldwide.

IBS Alumni Network

IBS boasts a robust alumni network of over 70,000 individuals, with nearly 40% in senior management positions and 10% in international roles.

Apply Now for IBSAT 2024

Apply for IBSAT 2024 today and embark on a transformative journey toward becoming an industry-ready professional. For more information, visit www.ibsindia.org.

 

Contact Information:
IBS Admission Office
Plot No. 65, Nagarjuna Hills
Punjagutta, Hyderabad – 500082
Telangana
Ph: 040 – 23440963 (5 lines)
E-mail: ibsat@ibsindia.org

Logo – https://mma.prnewswire.com/media/1023356/IBS_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/ibsat-2024-application-deadline-extended-to-december-23rd-302335427.html

Continue Reading

Technology

GienTech transforms enterprise software testing with the launch of a powerful AI-driven end-to-end solution

Published

on

By

Next-generation Testing Center of Excellence (TCoE 3.0) integrates AI, ML, and automation to make enterprise software testing faster, more responsive and efficient

HONG KONG, Dec. 19, 2024 /PRNewswire/ — Digital transformation specialist GienTech is revolutionizing the way enterprises approach software testing with the launch of a powerful new Testing Center of Excellence (TCoE 3.0) solution. Built on a platform of artificial intelligence (AI) and incorporating machine learning (ML), automation, and agile testing methodologies, TCoE 3.0 will support organizations to rapidly and efficiently develop mission-critical software for reliable and stable real-world use.

Enterprise software testing is extremely complex and time-consuming. According to Gartner*, product-testing teams will continue to face increasing complexity in applications and architecture, as well as shorter development cycles, in coming years. This pressure will be made more acute by the ongoing shortage of skilled engineers and the need to meet compliance regulations for data privacy and accessibility. At the same time, teams need to continue to automate an ever-growing backlog of manual tests. GienTech is empowering organizations to overcome these obstacles with an end-to-end solution that uses Generative AI to substantially streamline and enhance enterprise software testing.

William Wong, Senior Vice President of GienTech, said: “We are on a mission to make software testing more intelligent, agile, and efficient, while also reducing costs and labour intensity. TCoE 3.0 is a comprehensive end-to-end solution designed to standardize, centralize, and optimize enterprise software testing using AI, ML, and automation. It augments your software quality assurance team and is ideal for demanding environments, like the banking and finance sector, where complex system architectures, custom-built legacy systems, and highly sensitive data are the norm.”

Key features of TCoE 3.0 include:

AI-powered test case generation: TCoE 3.0 leverages large language models (LLMs) to analyse business requirements and automatically generate test cases. This approach ensures that the test cases are aligned with business objectives throughout the end-to-end testing. By automating test case preparation and enhancing agility, TCoE 3.0 enables testing teams to achieve broader coverage with minimal additional effort.

AI-powered script creation and auto-execution: TCoE 3.0 converts natural language descriptions of test scenarios into executable test scripts and automates the execution of these scripts for end-to-end coverage. This innovation simplifies testing for dynamic user interfaces and custom workflows, empowering non-technical users to create test scripts. It effectively covers a wide range of scenarios across complex architectures, reduces manual tasks, and significantly streamlines testing efforts. 

Smart and scalable adaptive testing: TCoE 3.0 incorporates self-adapting capabilities to manage changes in application flows as well as self-healing capabilities to automatically adjust to user interface changes. By seamlessly adapting to continuous software updates, TCoE 3.0 minimizes the need for frequent script maintenance due to minor changes, significantly reducing the time, effort, and costs involved in test script upkeep.

The launch of TCoE 3.0 caps off a year of great strides in AI by GienTech. In 2024, GienTech launched the “ORIGIEN AI+” initiative to spearhead breakthroughs in AI-related product innovation, dataset construction, and model training. It has already introduced intelligent solutions to enterprises across various industries, including finance, energy, and manufacturing. In April, GienTech signed a strategic cooperation agreement with Hong Kong Applied Science and Technology Research Institute (ASTRI). The first fruit of this collaboration is the newly released Financial Intelligent Assistant, a comprehensive toolkit built on GienTech’s AI agent technology framework and ASTRI’s RAG framework to help financial sector enterprises accelerate AI application development and digital employee adoption. Earlier this month, GienTech unveiled the ORIGIEN Financial Large Language Model, which is tailored exclusively for the financial sector. The model enhances financial insights and applications through targeted training and tuning with 700GB of financial data, focusing on banking scenarios to ensure precise alignment with industry needs.

“With the explosive growth of technology, the application of AI is becoming increasingly practical, particularly in the highly digitized financial sector, where AI is experiencing large-scale adoption. The industry requires not merely AI products or models, but a true realization of enterprise intelligence that transforms business models through AI. Centred around the application and scenarios, we are committed to unlocking the value of AI application. Combining advances in AI technology with our strengths in infrastructure, consulting, software, data governance, and large-scale customized services, GienTech can help enterprises achieve intelligent digitalization, enhance productivity, and improve profitability,” Wong continued.

* Gartner, “Market Guide for AI-Augmented Software Testing Tools” (13 February, 2024)

About GienTech

Founded in 1995, GienTech is an expert in intelligent digitalization strategies and software solutions, specializing in the financial and other key industries. GienTech has more than 40,000 employees across China and in overseas markets, serving over 800 financial institutions and more than 160 Fortune 500 companies. GienTech has ranked first in the IDC China banking IT solution market for seven consecutive years and has been selected in the global top 100 in the IDC Financial Insights FinTech ranking for nine consecutive years. Its strict quality and management principles have passed CMMIL5, ISO27001, ISO9001, ISO20000 and many other international certifications.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gientech-transforms-enterprise-software-testing-with-the-launch-of-a-powerful-ai-driven-end-to-end-solution-302335754.html

SOURCE GienTech

Continue Reading

Technology

Montrose Environmental Group Selected by Sydney Water to Install PFAS Treatment System

Published

on

By

LITTLE ROCK, Ark., Dec. 18, 2024 /PRNewswire/ — Montrose Environmental Group, Inc. (NYSE: MEG), a global environmental solutions company, was selected to install its per- and polyfluorinated substances (PFAS) mobile treatment system at Sydney Water’s Cascade Water Filtration Plant (WFP) outside of Sydney, Australia to address PFAS in drinking water.

In June 2024, perfluorooctane sulfonate (PFOS) and PFHxS, two forms of PFAS, were detected in the outlet of the Cascade WFP. Sydney Water took prompt action to find a solution that would quickly begin removing PFAS compounds from drinking water. 

As a leading provider of water treatment solutions in Australia and a pioneer in treating PFAS-impacted water in the country, Montrose was engaged by Sydney Water, Australia’s largest water utility, to implement a mobile solution for the immediate treatment of drinking water while Sydney Water pursues long-term upgrades to the Cascade WFP. Installing Montrose’s system at the WFP will help reduce PFAS to below the limits proposed in the draft Australian Drinking Water Guidelines, which are set to be finalized in April 2025.

Roch Cheroux, Managing Director of Sydney Water, commented: “We are committed to leading the way with new ideas to ensure the continued delivery of world-class drinking water to our communities. This initiative to install a rapid treatment system reflects our commitment to deliver safe and reliable water to all our customers.” 

Montrose is proud to be working with Sydney Water, which has a shared commitment to providing communities with safe drinking water,” said Vijay Manthripragada, president and chief executive officer of Montrose Environmental Group. “The installation of these multi-million-dollar systems underscores our commitment to the Australian market and achieves our organic growth goals in the region. By deepening our relationship with the broader Australian environmental services sector, we are confident in our prospects for 2025 and beyond.”

Contacts

Investor Relations:
Adrianne Griffin
(949) 988-3383
ir@montrose-env.com

Media Relations:
Lauren Dowling
(214)-514-9809
pr@montrose-env.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/montrose-environmental-group-selected-by-sydney-water-to-install-pfas-treatment-system-302335757.html

SOURCE Montrose Environmental Group, Inc.

Continue Reading

Trending